Elanco Animal Health Incorporated ELAN
Set alert
24.10 USD +1.04 +4.51%
At close
24.23 +0.13 +0.54%
Pre-market · Nov 3, 4:47 AM ET
23.31 Day range 24.23
19.40 52-week range 27.98
- YTD
- +6.50%
- 1 year
- +5.47%
- Open
- 23.55
- Prev close
- 23.06
- Mkt cap
- 12.04B
- Vol
- 6.54M
- Avg vol
- 6.15M
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.31
- High
- 24.23
- Forward P/E
- 18.93
- Beta
- 1.72
- Short ratio
- 5.57
- Inst. own
- 115.51%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2026
- 50-d avg
- 23.12
- 200-d avg
- 23.79
- 1y target
- 30.23
Analyst view
Consensus: buy
Buy
Price target (mean) 30.23 +25.4% upside
Now 24.10
- Target (low)
- 24.00
- Target (mean)
- 30.23
- Target (high)
- 34.00
Ratings (0m) 16 13 buy · 3 hold · 0 sell
- Strong buy4
- Buy9
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.20328 | 0.19 – 0.21 | 0.19 | +7.0% | 1.21B | +6.1% | 12 |
| Next quarter | 0.18323 | 0.17 – 0.195 | 0.13 | +40.9% | 1.19B | +4.2% | 11 |
| Current year | 1.13 | 1.10 – 1.15 | 0.94 | +20.3% | 5.13B | +8.8% | 14 |
| Next year | 1.27 | 1.22 – 1.40 | 1.13 | +12.6% | 5.41B | +5.4% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 20, 2026 | Jefferies | Downgrade | Buy | Hold |
| Oct 16, 2026 | Goldman Sachs | Initiated | — | Buy |
| Aug 6, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 22, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 18, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 15, 2026 | Citigroup | Initiated | — | Buy |
| Feb 25, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 25, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Feb 24, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Feb 19, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 22, 2026 | Piper Sandler | Upgrade | Neutral | Overweight |
| Dec 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 9, 2025 | Barclays | Initiated | — | Overweight |
| Nov 21, 2025 | Keybanc | Initiated | — | Overweight |
| Nov 6, 2025 | UBS | Maintained | Buy | Buy |
| Oct 20, 2025 | UBS | Maintained | Buy | Buy |
| Oct 7, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 24, 2025 | Stifel | Maintained | Buy | Buy |
| Aug 11, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 8, 2025 | UBS | Maintained | Buy | Buy |
| Jul 23, 2025 | UBS | Maintained | Buy | Buy |
| Jul 17, 2025 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Jul 2, 2025 | Stifel | Maintained | Buy | Buy |
| Jun 26, 2025 | William Blair | Upgrade | Market Perform | Outperform |
| May 19, 2025 | Stifel | Maintained | Buy | Buy |
| May 8, 2025 | Stifel | Maintained | Buy | Buy |